Prasequine 1mg Tablets

Pergolide 1.0 mg

Symptomatic treatment of clinical signs associated with Pituitary Pars Intermedia
Dysfunction (PPID) (Equine Cushing's Disease).

Do not use in horses with known hypersensitivity to pergolide mesilate or other ergot
derivatives or to any of the excipients.
Do not use in horses less than 2 years of age.

Pregnancy:
The safety of this veterinary medicinal product has not been demonstrated in
pregnant mares. Laboratory studies in mice and rabbits have not produced any
evidence of teratogenic effects. Reduced fertility was seen in mice at a dose of 5.6
mg/kg body weight per day. Use only according to the benefit/ risk assessment by the
responsible veterinarian.
Lactation:
The use is not recommended in lactating horses, in which the safety of this veterinary
medicinal product has not been demonstrated. In mice, reduced body weights and
survival rates in the progeny were attributed to the pharmacological inhibition of
prolactin secretion resulting in lactation failure.

Not authorised for use in horses intended for human consumption.
The horse must have been declared as not intended for human consumption under
national horse passport legislation.
Not authorised for use in mares producing milk for human consumption.